NEW YORK -(Dow Jones)- After difficult negotiations to lower its acquisition price of Guidant Corp. ( GDT), Johnson & Johnson (JNJ) could be seeing its work fall to the wayside after Boston Scientific Corp. ( BSX) came in with a higher offer Monday.
http://c.moreover.com/click/here.pl?r434090088
http://c.moreover.com/click/here.pl?r434090088